Precipio Inc
Change company Symbol lookup
Select an option...
PRPO Precipio Inc
LFLY Leafly Holdings Inc
QNRX Quoin Pharmaceuticals Ltd
INDP Indaptus Therapeutics Inc
RNAZ Transcode Therapeutics Inc
NEOV NeoVolta Inc
SYBX Synlogic Inc
FIISO Financial Institutions Inc
KA Kineta Inc
TCS Container Store Group Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Company profile

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Closing Price
$5.60
Day's Change
-100.48 (-94.72%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.35
Day's Low
4.75
Volume
(Heavy Day)
Volume:
169,477

10-day average volume:
29,869
169,477

Bank Of America Corp. Stock Outperforms Competitors Despite Losses On The Day

4:33 pm ET May 12, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bank of America Corp. (BAC) shed 1.10% to $27.09 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.16% to 4,124.08 and Dow Jones Industrial Average falling 0.03% to 33,300.62.

Bank of America Corp. closed $11.51 short of its 52-week high ($38.60), which the company achieved on November 11th.

Despite its losses, the stock outperformed some of its competitors Friday, as JPMorgan Chase & Co. (JPM) fell 1.43% to $134.10 and Wells Fargo & Co. (WFC) fell 2.19% to $37.49.

Trading volume (37.8 M) remained 32.1 million below its 50-day average volume of 69.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

May 12, 2023 16:33 ET (20:33 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.